Sidney Altman

Sidney Altman
NIH · Public domain · source
Name	Sidney Altman
Birth date	May 7, 1939
Birth place	Montreal, Quebec, Canada
Death date	May 5, 2022
Death place	Rockleigh, New Jersey, United States
Nationality	Canadian-American
Fields	Molecular biology, Biochemistry
Workplaces	Yale University, Columbia University, Medical Research Council Laboratory of Molecular Biology
Alma mater	Massachusetts Institute of Technology, University of Toronto
Known for	Ribonuclease P RNA catalytic activity
Awards	Nobel Prize in Chemistry (1989)

Sidney Altman was a Canadian-American molecular biologist and biochemist noted for demonstrating the catalytic role of RNA in the ribonuclease P complex. His work reshaped understanding of RNA function and informed research across Stanford University, Harvard University, Massachusetts Institute of Technology, University of Cambridge, and other institutions studying nucleic acids. Altman's discoveries influenced fields represented by researchers at Max Planck Society, Cold Spring Harbor Laboratory, European Molecular Biology Laboratory, and laboratories in the United States, United Kingdom, and Canada.

Early life and education

Altman was born in Montreal, Quebec, and raised in a family with roots in Poland and Russia. He attended local schools before enrolling at the Massachusetts Institute of Technology for undergraduate studies and then transferring to the University of Toronto for doctoral training in molecular biology and biochemistry. During his formative years he interacted with scholars from McGill University, Queen's University, University of British Columbia, and international visitors from Pasteur Institute and Karolinska Institute. His PhD work placed him in networks connected to investigators affiliated with National Institutes of Health, Medical Research Council, and the Royal Society.

Scientific career and research

Altman held positions at multiple research centers, including early postdoctoral affiliations at the Medical Research Council Laboratory of Molecular Biology and academic appointments at Columbia University and Yale University. His laboratory investigated ribonuclease P, drawing comparisons with studies from laboratories at University of California, Berkeley, California Institute of Technology, University of Wisconsin–Madison, and University of Chicago. Collaborations and scientific discourse connected his work to investigators at Rockefeller University, Johns Hopkins University, Salk Institute, and University of California, San Francisco.

Altman's research demonstrated that RNA can act as a biocatalyst, specifically that the RNA component of ribonuclease P possesses catalytic activity without protein cofactors. This finding linked to parallel discoveries in laboratories led by scientists associated with Stanford University and Princeton University concerning catalytic RNA and ribozymes. The work provided mechanistic insight relevant to studies at European Molecular Biology Laboratory, Max Planck Institute for Biophysical Chemistry, Whitehead Institute, and clinical research groups at Mayo Clinic and Cleveland Clinic investigating RNA-processing enzymes. His results informed theoretical frameworks developed by scholars from Columbia University, Cornell University, Brown University, and Duke University.

Altman trained graduate students and postdoctoral fellows who later held positions at institutions such as University of California, San Diego, University of Michigan, University of Pennsylvania, University of Texas Southwestern Medical Center, and Imperial College London. His methodological approaches intersected with techniques used at Argonne National Laboratory, Lawrence Berkeley National Laboratory, and synchrotrons employed by scientists at European Synchrotron Radiation Facility and Diamond Light Source.

Nobel Prize and major honors

In 1989 Altman shared the Nobel Prize in Chemistry with another scientist recognized for catalytic RNA, a prize paralleling honors given by organizations including the Royal Society, National Academy of Sciences, American Academy of Arts and Sciences, and Canadian Academy of Health Sciences. His award complemented accolades like the Lasker Award, Gairdner Foundation International Award, and medals from institutions such as Columbia University and Yale University.

He received honorary degrees and memberships from universities including Harvard University, University of Oxford, University of Edinburgh, McMaster University, and professional societies such as the American Chemical Society and Biophysical Society. Altman's recognition prompted lectureships at venues like Cold Spring Harbor Laboratory, Gordon Research Conferences, Royal Institution, and symposia hosted by Howard Hughes Medical Institute.

Personal life and legacy

Altman became a naturalized citizen of the United States and maintained ties to Canadian scientific communities including Canadian Institutes of Health Research and Genome Canada. He mentored scientists who went on to roles at NIH, FDA, and international agencies, contributing to policy and research at organizations such as the World Health Organization and United Nations Educational, Scientific and Cultural Organization. His legacy is preserved in collections and archives at institutions like Yale University and the American Philosophical Society and in curricula at universities including Stanford University, MIT, and Princeton University.

Altman's influence extended into biotechnology and industry collaborations with firms connected to translational research, including partnerships resembling those between academic labs and companies in the Cambridge Biomedical Campus, Silicon Valley, and biotechnology hubs in Boston. His contributions are cited in reviews and textbooks circulated through publishers affiliated with Elsevier, Springer Nature, and Oxford University Press.

Selected publications and contributions

Altman's key publications appeared in journals and proceedings alongside work from authors at Nature Publishing Group, Cell Press, Proceedings of the National Academy of Sciences, and Journal of Biological Chemistry. Major papers described the catalytic properties of ribonuclease P RNA, experimental evidence for RNA-mediated phosphodiester bond cleavage, and implications for molecular evolution debates involving researchers at Scripps Research, Weizmann Institute of Science, and Max Planck Institute for Molecular Genetics.

His contributions informed subsequent studies on RNA structure and function by investigators at University of California, Los Angeles, University of Toronto, McGill University, and University of Copenhagen. Reviews and summaries of his work have been presented at meetings hosted by American Society for Biochemistry and Molecular Biology, European Federation of Biotechnology, and International Union of Biochemistry and Molecular Biology.

Category:1939 births Category:2022 deaths Category:Canadian biochemists Category:American biochemists Category:Nobel laureates in Chemistry